29-03-2023 17:36 via prnewswire.com

Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial

Proof of concept STEP-52 trial shows treatment efficacy and stability of PTSD symptoms when moving from unregulated drug to APEX-52 GMP drug product. VANCOUVER, BC, March 29, 2023 /PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company optimizing the standard of...
Read more »